172 related articles for article (PubMed ID: 21334750)
21. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
22. The role of toll-like receptor ligands/agonists in protection against genital HSV-2 infection.
Gill N; Davies EJ; Ashkar AA
Am J Reprod Immunol; 2008 Jan; 59(1):35-43. PubMed ID: 18154594
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-12- and gamma interferon-dependent innate immunity are essential and sufficient for long-term survival of passively immunized mice infected with herpes simplex virus type 1.
Vollstedt S; Franchini M; Alber G; Ackermann M; Suter M
J Virol; 2001 Oct; 75(20):9596-600. PubMed ID: 11559791
[TBL] [Abstract][Full Text] [Related]
24. Natural history of murine gamma-herpesvirus infection.
Nash AA; Dutia BM; Stewart JP; Davison AJ
Philos Trans R Soc Lond B Biol Sci; 2001 Apr; 356(1408):569-79. PubMed ID: 11313012
[TBL] [Abstract][Full Text] [Related]
25. Early kinetics of innate and adaptive immune responses during hepatitis B virus infection.
Fisicaro P; Valdatta C; Boni C; Massari M; Mori C; Zerbini A; Orlandini A; Sacchelli L; Missale G; Ferrari C
Gut; 2009 Jul; 58(7):974-82. PubMed ID: 19201769
[TBL] [Abstract][Full Text] [Related]
26. Persistence of mucosal T-cell responses to herpes simplex virus type 2 in the female genital tract.
Posavad CM; Zhao L; Mueller DE; Stevens CE; Huang ML; Wald A; Corey L
Mucosal Immunol; 2015 Jan; 8(1):115-26. PubMed ID: 24917455
[TBL] [Abstract][Full Text] [Related]
27. Severe herpes virus (HSV-2) infection in two patients with myelodysplasia and undetectable NK cells and plasmacytoid dendritic cells in the blood.
Dalloul A; Oksenhendler E; Chosidow O; Ribaud P; Carcelain G; Louvet S; Massip P; Lebon P; Autran B
J Clin Virol; 2004 Aug; 30(4):329-36. PubMed ID: 15163423
[TBL] [Abstract][Full Text] [Related]
28. Characterization of the IFN-gamma T-cell responses to immediate early antigens in humans with genital herpes.
Braun RP; Payne LG; Dong L
Virol J; 2006 Jul; 3():54. PubMed ID: 16822314
[TBL] [Abstract][Full Text] [Related]
29. Cell-mediated immunity and immunosuppression in herpes simplex virus infection.
Rinaldo CR; Torpey DJ
Immunodeficiency; 1993; 5(1):33-90. PubMed ID: 8167747
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of interleukin-15 compromises CD4-dependent adaptive immune responses against herpes simplex virus 2.
Gill N; Ashkar AA
J Virol; 2009 Jan; 83(2):918-26. PubMed ID: 19004955
[TBL] [Abstract][Full Text] [Related]
31. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
[TBL] [Abstract][Full Text] [Related]
32. T-cell-mediated mechanisms involved in resolution of genital herpes simplex virus type 2 (HSV-2) infection of mice.
Milligan GN; Dudley-McClain KL; Young CG; Chu CF
J Reprod Immunol; 2004 Apr; 61(2):115-27. PubMed ID: 15063634
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-21 mRNA expression during virus infections.
Holm C; Nyvold CG; Paludan SR; Thomsen AR; Hokland M
Cytokine; 2006 Jan; 33(1):41-5. PubMed ID: 16406655
[TBL] [Abstract][Full Text] [Related]
34. Sensing herpes: more than toll.
Melchjorsen J
Rev Med Virol; 2012 Mar; 22(2):106-21. PubMed ID: 22020814
[TBL] [Abstract][Full Text] [Related]
35. Dual role of B cells in mediating innate and acquired immunity to herpes simplex virus infections.
Deshpande SP; Kumaraguru U; Rouse BT
Cell Immunol; 2000 Jun; 202(2):79-87. PubMed ID: 10896767
[TBL] [Abstract][Full Text] [Related]
36. Establishment of latent herpes simplex virus type 1 infection in resistant, sensitive, and immunodeficient mouse strains.
Ellison AR; Yang L; Voytek C; Margolis TP
Virology; 2000 Mar; 268(1):17-28. PubMed ID: 10683323
[TBL] [Abstract][Full Text] [Related]
37. Enrichment of herpes simplex virus type 2 (HSV-2) reactive mucosal T cells in the human female genital tract.
Posavad CM; Zhao L; Dong L; Jin L; Stevens CE; Magaret AS; Johnston C; Wald A; Zhu J; Corey L; Koelle DM
Mucosal Immunol; 2017 Sep; 10(5):1259-1269. PubMed ID: 28051084
[TBL] [Abstract][Full Text] [Related]
38. Host genetic factors in susceptibility to herpes simplex type 1 virus infection: contribution of polymorphic genes at the interface of innate and adaptive immunity.
Moraru M; Cisneros E; Gómez-Lozano N; de Pablo R; Portero F; Cañizares M; Vaquero M; Roustán G; Millán I; López-Botet M; Vilches C
J Immunol; 2012 May; 188(9):4412-20. PubMed ID: 22490439
[TBL] [Abstract][Full Text] [Related]
39. Prophylactic and therapeutic modulation of innate and adaptive immunity against mucosal infection of herpes simplex virus.
Uyangaa E; Patil AM; Eo SK
Immune Netw; 2014 Aug; 14(4):187-200. PubMed ID: 25177251
[TBL] [Abstract][Full Text] [Related]
40. Immuno-metabolic changes in herpes virus infection.
Chattopadhyay D; Mukhopadhyay A; Ojha D; Sadhukhan P; Dutta S
Cytokine; 2018 Dec; 112():52-62. PubMed ID: 29960669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
